Liraglutide Versus Sitagliptin in a 24-week, Multicenter, Open-label, Randomized, Parallel-group Study in Japanese Type 2 Diabetes Mellitus Patients Responding Inadequately to a Sulfonylurea and/or One or Two Other Oral Antidiabetic Drugs (JDDM 33).

Yokoyama, Hiroki; Hirao, Koichi; Yamaguchi, Kohei; Oishi, Mariko; Lee, Gendai; Yagi, Noriharu; Takamura, Hiroshi; Kashiwagi, Atsunori

Yokoyama, Hiroki; Hirao, Koichi; Yamaguchi, Kohei; Oishi, Mariko; Lee, Gendai; Yagi, Noriharu; Takamura, Hiroshi; Kashiwagi, Atsunori.

Afiliação

Yokoyama H; Jiyugaoka Medical Clinic, Internal Medicine, Obihiro, Japan.
Hirao K; HEC Science Clinic, Yokohama, Japan.
Yamaguchi K; Kaiseikai Tsutsumi Hospital, Hitoyoshi, Japan.
Oishi M; Oishi Clinic, Kyoto, Japan.
Lee G; Lee Medical Clinic, Kitakyushu, Japan.
Yagi N; Yagi Medical Clinic, Naha, Japan.
Takamura H; Takamura Internal Medicine Clinic, Fussa, Japan.
Kashiwagi A; Kusatsu General Hospital, Kusatsu, Japan.

Jpn Clin Med ; 5: 33-41, 2014.

Article em En | MEDLINE | ID: mdl-25288908

Palavras-chave

C peptide; RCT; Type 2 diabetes; liraglutide; sitagliptin; sulfonylurea; ß Cell function

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2014 Tipo de documento: Article